Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathway

Ischemia-reperfusion injury (IRI) is a major obstacle in liver transplantation, especially with steatotic donor livers. Dysbiosis of the gut microbiota has been implicated in modulating IRI, and Lachnospiraceae plays a pivotal role in regulating host inflammatory and immune responses, but its specif...

Full description

Saved in:
Bibliographic Details
Main Authors: Shenghe Deng, Huan Cao, Tongxi Li, Xueling Wang, Junpeng Meng, Teng Zeng, Di Zhang, Shuhua Zhang, Guoliang Wang, Ran Liu, Tianhao Zou, Mao Cai, Ren Lang, Di Lu, Jinyang Gu
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Gut Microbes
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19490976.2025.2460543
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832579308059623424
author Shenghe Deng
Huan Cao
Tongxi Li
Xueling Wang
Junpeng Meng
Teng Zeng
Di Zhang
Shuhua Zhang
Guoliang Wang
Ran Liu
Tianhao Zou
Mao Cai
Ren Lang
Di Lu
Jinyang Gu
author_facet Shenghe Deng
Huan Cao
Tongxi Li
Xueling Wang
Junpeng Meng
Teng Zeng
Di Zhang
Shuhua Zhang
Guoliang Wang
Ran Liu
Tianhao Zou
Mao Cai
Ren Lang
Di Lu
Jinyang Gu
author_sort Shenghe Deng
collection DOAJ
description Ischemia-reperfusion injury (IRI) is a major obstacle in liver transplantation, especially with steatotic donor livers. Dysbiosis of the gut microbiota has been implicated in modulating IRI, and Lachnospiraceae plays a pivotal role in regulating host inflammatory and immune responses, but its specific role in liver transplantation IRI remains unclear. This study explores whether Lachnospiraceae can mitigate IRI and its underlying mechanisms. We found Lachnospiraceae-bacterium (Lachn.) abundance was significantly reduced in rats with liver cirrhosis. Lachn.-treated rats exhibited improved intestinal permeability, reduced IRI severity in both normal and steatotic donor livers, and decreased levels of neutrophil and macrophage infiltration, and inflammatory cytokines. Multi-omics analysis revealed elevated pyruvate levels in transplanted livers after Lachn. treatment, alongside reduced Alox15 and Foxo3 expression. Mechanistically, Lachn.-derived pyruvate inhibited Alox15 expression and reduced ferroptosis in normal and steatotic donor livers. Furthermore, reduced nuclear translocation of Foxo3 further suppressed Alox15 expression, alleviating IRI, especially in steatotic donor livers. Clinical samples confirmed reduced donor livers IRI in cirrhotic recipients with high Lachn. abundance after liver transplantation. In conclusion, Lachn. alleviates IRI in steatotic donor liver transplantation by inhibiting ferroptosis via the Foxo3-Alox15 axis, providing a potential therapeutic strategy to modulate gut microbiota to alleviate IRI following liver transplantation.
format Article
id doaj-art-caed6151eb4340c4837cc7d343fb557d
institution Kabale University
issn 1949-0976
1949-0984
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Gut Microbes
spelling doaj-art-caed6151eb4340c4837cc7d343fb557d2025-01-30T12:32:08ZengTaylor & Francis GroupGut Microbes1949-09761949-09842025-12-0117110.1080/19490976.2025.2460543Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathwayShenghe Deng0Huan Cao1Tongxi Li2Xueling Wang3Junpeng Meng4Teng Zeng5Di Zhang6Shuhua Zhang7Guoliang Wang8Ran Liu9Tianhao Zou10Mao Cai11Ren Lang12Di Lu13Jinyang Gu14Center for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaCenter for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaCenter for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaCenter for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of General Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, ChinaCenter for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaCenter for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaCenter for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaCenter for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaCenter for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaCenter for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaCenter for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of Hepatobiliary Surgery, Beijing Chao-Yang Hospital Affiliated to Capital Medical University, Beijing, ChinaKey Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, ChinaCenter for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaIschemia-reperfusion injury (IRI) is a major obstacle in liver transplantation, especially with steatotic donor livers. Dysbiosis of the gut microbiota has been implicated in modulating IRI, and Lachnospiraceae plays a pivotal role in regulating host inflammatory and immune responses, but its specific role in liver transplantation IRI remains unclear. This study explores whether Lachnospiraceae can mitigate IRI and its underlying mechanisms. We found Lachnospiraceae-bacterium (Lachn.) abundance was significantly reduced in rats with liver cirrhosis. Lachn.-treated rats exhibited improved intestinal permeability, reduced IRI severity in both normal and steatotic donor livers, and decreased levels of neutrophil and macrophage infiltration, and inflammatory cytokines. Multi-omics analysis revealed elevated pyruvate levels in transplanted livers after Lachn. treatment, alongside reduced Alox15 and Foxo3 expression. Mechanistically, Lachn.-derived pyruvate inhibited Alox15 expression and reduced ferroptosis in normal and steatotic donor livers. Furthermore, reduced nuclear translocation of Foxo3 further suppressed Alox15 expression, alleviating IRI, especially in steatotic donor livers. Clinical samples confirmed reduced donor livers IRI in cirrhotic recipients with high Lachn. abundance after liver transplantation. In conclusion, Lachn. alleviates IRI in steatotic donor liver transplantation by inhibiting ferroptosis via the Foxo3-Alox15 axis, providing a potential therapeutic strategy to modulate gut microbiota to alleviate IRI following liver transplantation.https://www.tandfonline.com/doi/10.1080/19490976.2025.2460543Lachnospiraceae-bacteriumsteatotic donor liversferroptosisliver transplantationAlox15
spellingShingle Shenghe Deng
Huan Cao
Tongxi Li
Xueling Wang
Junpeng Meng
Teng Zeng
Di Zhang
Shuhua Zhang
Guoliang Wang
Ran Liu
Tianhao Zou
Mao Cai
Ren Lang
Di Lu
Jinyang Gu
Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathway
Gut Microbes
Lachnospiraceae-bacterium
steatotic donor livers
ferroptosis
liver transplantation
Alox15
title Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathway
title_full Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathway
title_fullStr Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathway
title_full_unstemmed Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathway
title_short Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathway
title_sort lachnospiraceae bacterium alleviates ischemia reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the foxo3 alox15 signaling pathway
topic Lachnospiraceae-bacterium
steatotic donor livers
ferroptosis
liver transplantation
Alox15
url https://www.tandfonline.com/doi/10.1080/19490976.2025.2460543
work_keys_str_mv AT shenghedeng lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway
AT huancao lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway
AT tongxili lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway
AT xuelingwang lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway
AT junpengmeng lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway
AT tengzeng lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway
AT dizhang lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway
AT shuhuazhang lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway
AT guoliangwang lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway
AT ranliu lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway
AT tianhaozou lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway
AT maocai lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway
AT renlang lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway
AT dilu lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway
AT jinyanggu lachnospiraceaebacteriumalleviatesischemiareperfusioninjuryinsteatoticdonorliverbyinhibitingferroptosisviathefoxo3alox15signalingpathway